Condition: Androgenetic Alopecia · Female Pattern Baldness · Sponsor: Industrial Farmacéutica Cantabria, S.A.
The goal of this clinical trial is to learn about oral minoxidil 1mg in the treatment of women with androgenetic alopecia, a type of hormone-imbalanced hair loss. The main questions to answer are to know about that minoxidil 1mg is as effective as minoxidil 2% topical solution (comparator product) and is more effective than placebo; and to ensure treatment with oral minoxidil is safe. Participants will be assigned randomly to receive one of the following treatment combinations: * the test product (oral minoxidil 1 mg, once/day) and the vehicle solution (vehicle means it looks like the comparator product, but it does not contain an active ingredient, 2 times/day), or * the placebo tablet (placebo means it looks like the test product, but it does not contain an active ingredient, once/day) and the comparator product (2% minoxidil solution, 2 times/day), or * the placebo tablet (once/day) and the vehicle solution (2 times/day). The clinical trial will take up to 36 weeks. During this time, patients will come to the clinical trial centre for 5 times for examinations and will be called by phone twice. At the visits, the following examinations will be performed: photos of the hair will be taken to determine hair density, assessment of changes in scalp hair growth, measurement of blood pressure, pulse, and body temperature, a physical examination, blood withdrawal to determine any abnormalities in the blood, urine sampling and analysis, performance of ECG, and evaluation of hype…
This description comes directly from the study's public registry record.
Ana López-Ballesteros · +34671778847 · ana.lopez@cantabrialabs.es
Juan José Andrés Lencina · +34674533821 · juanjose.andres@cantabrialabs.es
Always discuss trial participation with your own doctor first.
| Fachklinik Bad Bentheim Klinisches Studienzentrum | Bad Bentheim, Germany | Recruiting |
| CRC - Charité Universitätsmedizin Berlin Clinical Research Center for Hair and Skin Science | Berlin, Germany | Recruiting |
| emovis by Futuremeds GmbH | Berlin, Germany | Recruiting |
| Rosenpark Reasearch GmbH | Darmstadt, Germany | Not Yet Recruiting |
| Privatpraxis Dr. Hilton & Partner | Düsseldorf, Germany | Terminated |
| Klinik für Dermatologie, Venerologie und Allergologie - Universitätsmedizin Frankfurt | Frankfurt, Germany | Recruiting |
| Dermaticum -Dr. med. Mario Bittar und Kollegen | Freiburg im Breisgau, Germany | Recruiting |
| Eurofins bioskin - Research Center Dermatology | Hamburg, Germany | Recruiting |
| Klinische Forschung Karlsruhe GmbH | Karlsruhe, Germany | Recruiting |
| Siteworks - Prüfzentrum Lohne | Löhne, Germany | Active Not Recruiting |
| Zentrale Studienkoordination für innovative Dermatologie (ZiD) Klinik für Hautkrankheiten Universitätsklinikum Münster (UKM) | Münster, Germany | Withdrawn |
| Haut-und Lasercentrum - Dr. Tanja Fischer und Kollegen | Potsdam, Germany | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05888922